The Power of a Prescription - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

The Power of a Prescription

April Jasper, OD, FAAO, discusses the importance of keeping patients' trust as technology evolves.

  • By

  • April Jasper, OD, FAAO

  • September 1, 2026

  • 4 min

Share

Clinical Scorecard: The Power of a Prescription

At a Glance

CategoryDetail
ConditionPatient Trust in Healthcare
Key MechanismsActive listening and effective communication
Target PopulationPatients seeking healthcare services
Care SettingClinical practice environments

Key Highlights

  • Less than 50% of respondents feel 'health secure'.
  • Only 25% fully endorse their current health care system.
  • Erosion of trust can lead to negative health consequences.
  • Practices that show empathy and kindness grow their patient base.
  • Patients expect treatment plans and guidance during visits.

Guideline-Based Recommendations

Diagnosis

  • Ask the right questions to reach accurate diagnoses.

Management

  • Provide clear treatment plans and prescriptions.

Monitoring & Follow-up

  • Engage in active listening to understand patient needs.

Risks

  • Ignoring patient concerns can erode trust and impact health outcomes.

Patient & Prescribing Data

Patients visiting healthcare practices for eye care.

Patients often leave without prescriptions or treatment guidance.

Clinical Best Practices

  • Focus on patient well-being and communication.
  • Build trust through empathy and active listening.
  • Educate patients about treatment options and health risks.

Related Resources & Content

Original Source(s)

The Power of a Prescription

  • by April Jasper, OD, FAAO

  • September 1, 2026

Related Content

Scleral Lens Evolution

This article will examine the indications, clinical evidence, and practical considerations for managing severe ocular surface disease and inflammatory dry eye using scleral lenses, and offer guidance to practitioners who seek to expand their therapeutic options.

Biologics Tied to Lower Eye Risk in Psoriasis

Real-world data suggest lower rates of ocular surface disease with biologics vs nonbiologic systemic therapy.

Women and Dry Eye

Presenters at Optometry's Meeting noted that hormonal status and cosmetic use can significantly affect test results and dry eye disease presentation.